Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Statewide collaborative partnerships among American Indian and Alaska Native (AI/AN) communities in California to target the opioid epidemic: Preliminary results of the Tribal Medication Assisted Treatment (MAT) key informant needs assessment.
Zeledon I, West A, Antony V, Telles V, Begay C, Henderson B, Unger JB, Soto C. Zeledon I, et al. Among authors: telles v. J Subst Abuse Treat. 2020 Jan;108:9-19. doi: 10.1016/j.jsat.2019.04.003. Epub 2019 Apr 10. J Subst Abuse Treat. 2020. PMID: 31056429
Rationale and design of a pilot randomized controlled trial to increase moderate-to-vigorous physical activity in preadolescent Latina girls and their mothers.
Arredondo EM, Schneider J, Torres-Ruiz M, Telles V, Thralls Butte K, West M, Maldonado M, Gallagher K, Roesch S, Ayala GX, Baranowski T. Arredondo EM, et al. Among authors: telles v. Contemp Clin Trials Commun. 2023 Apr 20;33:101137. doi: 10.1016/j.conctc.2023.101137. eCollection 2023 Jun. Contemp Clin Trials Commun. 2023. PMID: 37215388 Free PMC article.
C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 'LIVE-AIR' trial.
Temesgen Z, Kelley CF, Cerasoli F, Kilcoyne A, Chappell D, Durrant C, Ahmed O, Chappell G, Catterson V, Polk C, Badley A, Marconi VC; LIVE-AIR Study Group. Temesgen Z, et al. Thorax. 2023 Jun;78(6):606-616. doi: 10.1136/thoraxjnl-2022-218744. Epub 2022 Jul 6. Thorax. 2023. PMID: 35793833 Free PMC article. Clinical Trial.
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.
Temesgen Z, Burger CD, Baker J, Polk C, Libertin CR, Kelley CF, Marconi VC, Orenstein R, Catterson VM, Aronstein WS, Durrant C, Chappell D, Ahmed O, Chappell G, Badley AD; LIVE-AIR Study Group. Temesgen Z, et al. Lancet Respir Med. 2022 Mar;10(3):237-246. doi: 10.1016/S2213-2600(21)00494-X. Epub 2021 Dec 1. Lancet Respir Med. 2022. PMID: 34863332 Free PMC article. Clinical Trial.
Phenome-Wide Scan Finds Potential Orofacial Risk Markers for Cancer.
Bezamat M, Harrison B, Zhou Y, Glickman KM, Telles V, Guirguis C, Modesto A, Vieira AR. Bezamat M, et al. Among authors: telles v. Sci Rep. 2020 Mar 17;10(1):4869. doi: 10.1038/s41598-020-61654-3. Sci Rep. 2020. PMID: 32184411 Free PMC article.
18 results